SCHEMBL31567046

SCHEMBL31567046

CC(C)(C)OC(=O)N1CCC(C(=O)O)(C2CC2)C1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.41
USP2 O75604 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GPR119 Q8TDV5 3/20 0.40
RECQL P46063 1/20 0.40
EPHX1 P07099 1/20 0.40
USP30 Q70CQ3 1/20 0.39
SCD5 Q86SK9 1/20 0.38
EPHX2 P34913 1/20 0.38
CYP11B2 P19099 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
HSD17B10 Q99714 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
PTPN2 P17706 1/20 0.36
PTPN1 P18031 1/20 0.36
PTPN6 P29350 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29215662 0.91 USP2 (0.49) HPGDUSP2SMN1; SMN2GPR119RECQL
SCHEMBL31231171 0.91 USP2 (0.49) HPGDUSP2SMN1; SMN2GPR119RECQL
SCHEMBL396843 0.85 EPHX1 (0.49) HPGDUSP2SMN1; SMN2GPR119RECQL
SCHEMBL4609802 0.84 EPHX1 (0.51) HPGDUSP2SMN1; SMN2GPR119RECQL
SCHEMBL25271054 0.82 HPGD (0.44) HPGDUSP2SMN1; SMN2GPR119RECQL
SCHEMBL30342339 0.82 NR1H2 (0.39) HPGDUSP2SMN1; SMN2GPR119RECQL
SCHEMBL20415351 0.82 NR1H2 (0.39) HPGDUSP2SMN1; SMN2GPR119RECQL
SCHEMBL19410867 0.82 HPGD (0.50) HPGDUSP2SMN1; SMN2GPR119RECQL
SCHEMBL31170608 0.81 HPGD (0.47) HPGDUSP2SMN1; SMN2GPR119RECQL
SCHEMBL20564971 0.79 EPHX2 (0.41) HPGDUSP2SMN1; SMN2GPR119RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096637-A1 SUBSTITUTED ARYL SULFONAMIDES FOR USE AS SODIUM CHANNEL INHIBITORS XENON PHARMACEUTICALS INC. (CA) 2025-05-08 WO disclosed